A method of reducing damage to the ovary of a subject receiving chemotherapy is described. The method comprises the step of administering to the subject an amount of a proteasome inhibitor effective to reduce damage to the subjects ovary within a therapeutic time window prior to administration of a chemotherapeutic agent.